Literature DB >> 16187145

Limitations and technical considerations of endovascular treatment in neonates with high-flow arteriovenous shunts presenting with congestive heart failure: report of two cases.

Shinichi Nakano1, Ronit Agid, Paula Klurfan, Marlise Peruzzo dos Santos Souza, Derek Armstrong, Karel G Terbrugge.   

Abstract

CASE REPORT: We report two neonatal patients with high-flow intracranial or cervical arteriovenous (AV) shunts who presented with congestive heart failure and were successfully managed with endovascular treatment. One with vein of Galen malformation with body weight of only 2.0 kg is, to our knowledge, the smallest neonate successfully treated with endovascular treatment. The other neonate is, to our knowledge, the first vertebro-vertebral fistula patient presenting with heart failure and treated successfully with endovascular treatment.
CONCLUSION: Even in neonates, endovascular treatment is the procedure of choice for high-flow AV shunts presenting with progressive congestive heart failure resistant to medical management. We discuss limitations and technical considerations of endovascular treatments in small neonates with high-flow AV shunts and congestive heart failure.

Entities:  

Mesh:

Year:  2005        PMID: 16187145     DOI: 10.1007/s00381-005-1237-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  21 in total

1.  Vein of Galen management in neonatal period.

Authors:  K G terBrugge
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

2.  Neonatal vein of Galen aneurysms: severe coagulopathy associated with transtorcular embolization.

Authors:  E M Rosenberg; G B Nazar
Journal:  Crit Care Med       Date:  1991-03       Impact factor: 7.598

3.  A 4-F coaxial catheter system for pediatric vascular occlusion with detachable balloons.

Authors:  P E Burrows; P LasJaunias; K G TerBrugge
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

Review 4.  Interventional neuroradiology.

Authors:  W Taylor; G Rodesch
Journal:  BMJ       Date:  1995-09-23

5.  Endovascular management of vein of Galen aneurysmal malformations presenting in the neonatal period.

Authors:  P J Mitchell; J V Rosenfeld; P Dargaville; P Loughnan; M R Ditchfield; G Frawley; B M Tress
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

6.  Vein of Galen aneurysmal malformation: diagnosis and treatment of 13 children with extended clinical follow-up.

Authors:  Blaise V Jones; William S Ball; Thomas A Tomsick; Justin Millard; Kerry R Crone
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

7.  Recent improvement in outcome using transcatheter embolization techniques for neonatal aneurysmal malformations of the vein of Galen.

Authors:  D M Friedman; R Verma; M Madrid; J H Wisoff; A Berenstein
Journal:  Pediatrics       Date:  1993-03       Impact factor: 7.124

8.  Vein of Galen malformation. Endovascular management of 43 cases.

Authors:  P Lasjaunias; R Garcia-Monaco; G Rodesch; K Ter Brugge; M Zerah; M Tardieu; D de Victor
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

9.  Therapeutic alternatives for vein of Galen vascular malformations.

Authors:  P Lylyk; F Viñuela; J E Dion; G Duckwiler; G Guglielmi; W Peacock; N Martin
Journal:  J Neurosurg       Date:  1993-03       Impact factor: 5.115

10.  Severe cardiac failure in newborns with VGAM. Prognosis significance of hemodynamic parameters in neonates presenting with severe heart failure owing to vein of Galen arteriovenous malformation.

Authors:  L Chevret; P Durand; H Alvarez; V Lambert; L Caeymax; G Rodesch; D Devictor; P Lasjaunias
Journal:  Intensive Care Med       Date:  2002-07-05       Impact factor: 17.440

View more
  1 in total

Review 1.  Endovascular management of pediatric high-flow vertebro-vertebral fistula with reversed basilar artery flow. A case report and review of the literature.

Authors:  A R Honarmand; S A Ansari; T D Alden; M Soltanolkotabi; S E Schoeneman; M C Hurley; O Rahman; A Shaibani
Journal:  Interv Neuroradiol       Date:  2013-05-21       Impact factor: 1.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.